Page 1 | Search Results | Cancer Immunology Research | American Association for Cancer Research

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Abstract A14: Surgical removal of metastatic lesions increases T-cell reactivity to tumor-associated antigens in stage III melanoma patients

Yago Pico de Coaña, Fríða Björk Gunnarsdóttir, Maria Wolodarski, Suzanne Egyhazi Brage, Giuseppe Masucci, Johan Hansson, Rolf Kiessling

Cancer Immunol Res (2018) 6 (9_Supplement): A14.

https://doi.org/10.1158/2326-6074.TUMIMM17-A14

Published: 01 September 2018

View articletitled, Abstract A14: Surgical removal of metastatic lesions increases T-cell reactivity to tumor-associated antigens in stage III melanoma patients

Journal Articles

Abstract B026: MDSCs and CD8 effector memory T cells correlate with survival in melanoma patients treated with ipilimumab

Yago Pico De Coaña, Maria Wolodarski, Isabel Poschke, Yuya Yoshimoto, Giuseppe Masucci, Johan Hansson, Rolf Kiessling

Cancer Immunol Res (2016) 4 (11_Supplement): B026.

https://doi.org/10.1158/2326-6066.IMM2016-B026

Published: 31 October 2016

View articletitled, Abstract B026: MDSCs and CD8 effector memory T cells correlate with survival in melanoma patients treated with ipilimumab

Journal Articles

Abstract A071: Immune monitoring of ipilimumab treated patients reveals enhanced CD4+ T cell activation correlated with diminished MDSCs

Yago Pico de Coaña, Maria Wolodarski, Yuya Yoshimoto, Giusy Gentilcore, Isabel Poschke, Giuseppe V. Masucci, Johan Hansson, Rolf Kiessling

Cancer Immunol Res (2016) 4 (1_Supplement): A071.

https://doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-A071

Published: 03 January 2016

View articletitled, Abstract A071: Immune monitoring of ipilimumab treated patients reveals enhanced CD4+ T cell activation correlated with diminished MDSCs

Journal Articles

Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

Yago Pico de Coaña, Isabel Poschke, Giusy Gentilcore, Yumeng Mao, Maria Nyström, Johan Hansson, Giuseppe V. Masucci, Rolf Kiessling

Cancer Immunol Res (2013) 1 (3): 158–162.

https://doi.org/10.1158/2326-6066.CIR-13-0016

Published: 08 September 2013

View articletitled, Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

Includes: Supplementary data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract A14: Surgical removal of metastatic lesions increases T-cell reactivity to tumor-associated antigens in stage III melanoma patients

Abstract B026: MDSCs and CD8 effector memory T cells correlate with survival in melanoma patients treated with ipilimumab

Abstract A071: Immune monitoring of ipilimumab treated patients reveals enhanced CD4+ T cell activation correlated with diminished MDSCs

Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

Email alerts

AACR Journals

Update search

Abstract A14: Surgical removal of metastatic lesions increases T-cell reactivity to tumor-associated antigens in stage III melanoma patients

Abstract B026: MDSCs and CD8 effector memory T cells correlate with survival in melanoma patients treated with ipilimumab

Abstract A071: Immune monitoring of ipilimumab treated patients reveals enhanced CD4+ T cell activation correlated with diminished MDSCs

Ipilimumab Treatment Results in an Early Decrease in the Frequency of Circulating Granulocytic Myeloid-Derived Suppressor Cells as well as Their Arginase1 Production

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only